Economic Evaluation of a Cannabinoid Oil for Treatment Resistant Epilepsy in Dravet SyndromeDravet Syndrome is a rare childhood epilepsy syndrome that is commonly associated with treatment-resistant epilepsy, despite best medical treatment. It is estimated that one in 15,700 children will be diagnosed with the condition, most of which will experience seizures in their first year of life. The focus for treatment is to reduce the frequency and […]

The post Economic Evaluation of a Cannabinoid Oil for Treatment Resistant Epilepsy in Dravet Syndrome appeared first on Sapphire Medical Clinics.